Healthy Subject Protocol
Healthy Subject Protocol - Related Videos
01:15
Bioavailability Study Design: Healthy Subjects Versus Patients
0 Views •
2025
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
06:57
Effects of Surgical Masks on Cardiopulmonary Function in Healthy Subjects
0 Views •
Cited by 15 •
2021
We study the effect of surgical masks on cardiopulmonary function based on a cardiopulmonary exercise test (CPET). This study shows that surgical masks reduce cardiopulmonary exercise capacity and ventilation in healthy young subjects and wearing masks might affect aerobic exercise capacity more in female subjects than in male subjects.
11:26
Home-Based Transcranial Direct Current Stimulation Device Development: An Updated Protocol Used at Home in Healthy Subjects and Fibromyalgia Patients
0 Views •
Cited by 53 •
2018
This study provides an updated home-based tDCS protocol that enables subjects to receive the beneficial effects of tDCS at home with an easy to use device with settings to control the use and dosage, enhancing the feasibility for long-term use at home.
08:21
Non-invasive Assessments of Subjective and Objective Recovery Characteristics Following an Exhaustive Jump Protocol
0 Views •
Cited by 7 •
2017
This protocol describes the procedure for non-invasive recovery assessments during a 72 h recovery period. This protocol induces muscular exhaustion of the frontal thighs using countermovement jumps and uses either local cold-cuff or thermoneutral-cuff application as a recovery modality.
06:12
Virtual Prism Adaptation Therapy: Protocol for Validation in Healthy Adults
0 Views •
Cited by 14 •
2020
This experimental protocol demonstrates the use of virtual prism adaptation therapy (VPAT) in healthy adults and the association between VPAT and functional near infrared spectroscopy to determine the effect of VPAT on cortical activation. Results suggest that VPAT may be feasible and could induce similar behavioral adaptation as conventional prism adaptation therapy.
FAQs
Its analytical value comes from establishing measurements in participants who do not have the condition under investigation. Eligibility criteria and standardized procedures limit differences unrelated to the intervention, making changes in vital signs, laboratory values, symptoms, or treatment responses easier to interpret. This baseline can clarify which effects are associated with the intervention rather than with underlying disease.
Eligibility screening helps create a study group that fits the research question, while standardized measurements make observations more consistent across participants. Together, these controls improve data quality and reduce avoidable variation. Consistency is especially important when researchers compare responses from healthy subjects with data from patients or evaluate changes during an early-phase clinical study.
Researchers can use healthy-subject measurements as a baseline for interpreting patient data, but the groups should not be treated as interchangeable. Differences between them may reflect the disease or condition rather than the intervention alone. Comparing vital signs, laboratory values, symptoms, or responses in this context helps clarify treatment effects and supports more informed interpretation.
Participant protection depends on informed consent, eligibility screening, standardized study procedures, and oversight. Researchers may monitor vital signs, laboratory values, symptoms, and responses to an intervention so that safety information is collected systematically. These safeguards help balance the scientific value of controlled measurements with the responsibility to protect participants during medical research.
A typical process begins with eligibility screening and informed consent, followed by standardized procedures and controlled measurements. Researchers then collect relevant observations, which may include vital signs, laboratory values, symptoms, and responses to an intervention. The resulting data are evaluated as a baseline or comparison point, with oversight supporting participant safety and study quality.
They support several types of medical research, including early-phase clinical studies, pharmacokinetic and pharmacodynamic assessments, and device evaluation. Pharmacokinetic work examines how an intervention is handled in the study, while pharmacodynamic work focuses on responses to it. Controlled observations in healthy participants can provide information needed before research advances to affected populations.
Results can help researchers judge whether an intervention is suitable for later studies involving people with the relevant disease or condition. Measurements of safety, laboratory values, symptoms, and responses provide evidence about treatment effects and study feasibility. Careful design and oversight also strengthen the reliability of conclusions carried forward into research with affected populations.